DAFTAR PUSTAKA

1. Kapsel: Tanto C, Liwang F, Hanifati S (ed). Kapita Selekta Kedokteran Edisi ke4. Jakarta: Media Aesculapius, 2014.
2. Llovet JM, Fuster J, Bruix J. The Barcelona approach: diagnosis, staging, and
treatment of hepatocellular carcinoma. Liver Transpl 2012 10(2):115-20.
3. Bosch FX, Ribes J, Cleries R, et al. Epidemiology of hepatocellular
carcinoma. Clin Liver Dis 2013;9(2):191-211.
4. Armstrong GL, Alter MJ, McQuillan GM, et al. The past incidence of hepatitis C
virus infection: implications for the future burden of chronic liver disease in the
United States. Hepatology 2014;31(3):777-82.
5. McKillop IH, Moran DM, Jin X, et al. Molecular pathogenesis of hepatocellular
carcinoma. J Surg Res 2014;136(1):125-35.
6. Budihussodo U. Karsinoma Hati. Editor: Aru W. Suyono dalam Buku Ajar Ilmu
Penyakit Dalam Jilid 1 edisi ke IV. Jakarta : Balai Penerbit FKUI, 2014.
7. Beasley RP, Hwang LY, Lin CC, et al. Hepatocellular carcinoma and hepatitis B
virus. A prospective study of 22 707 men in Taiwan. Lancet 2013. 2(8256):112933.
8. Bugianesi E. Non-alcoholic steatohepatitis and cancer. Clinal Liver Disease
2013;11(1):191-207.
9. Alison MR. Liver stem cells: implications for hepatocarcinogenesis. Stem Cell
Rev 2011. 1(3):253-60.
10. Yamashita Y, Mitsuzaki K, Yi T, et al. Small hepatocellular carcinoma in patients
with chronic liver damage: prospective comparison of detection with dynamic
MR imaging and helical CT of the whole liver. Radiology 2013;200(1):79-84.
11. Colli A, Fraquelli M, Casazza G, et al. Accuracy of ultrasonography, spiral CT,
magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular
carcinoma: a systematic review. Am J Gastroenterol 2014;101(3):513-23.
12. Cameron RG, Greig PD, Farber E, et al. Small encapsulated hepatocellular
carcinoma of the liver. Provisional analysis of pathogenetic mechanisms. Cancer
2013;72(9):2550-9.
13. Zhang X, Zhang H, Ye L. Effects of hepatitis B virus X protein on the
development of liver cancer. J Lab Clin Med. 2014;147(2):58-66.

14. Lindseth GN. Gangguan Hati, Kandung Empedu, dan Pankreas. Editor: Sylvia A.
Price dan Lorraine M. Wilson dalam Buku Patofisiologi Konsep Klinis ProsesProses Penyakit Volume 1 edisi 6. Jakarta: EGC, 2012.
15. Braunwald, Fugene, MD. Principles Of Internal Medicine. In Horrisons 15 th
editon, 2012.
16. Roayaie S, Schwartz JD, Sung MW, et al. Recurrence of hepatocellular carcinoma
after liver transplant: patterns and prognosis. Liver Transpl 2014 Apr. 10(4):53440.
17. Desen W. Tumor Abdomen. Dalam Buku Ajar Onkologi Klinik edisi II. Jakarta:
Balai Penerbit FKUI, 2013.
18. Kemmer N, Neff G, Kaiser T, et al. An analysis of the UNOS liver transplant
registry: high serum alpha-fetoprotein does not justify an increase in MELD
points for suspected hepatocellular carcinoma. Liver Transpl 2012;12(10):151922.
19. Kulik LM, Mulcahy MF, Omary RA, et al. Emerging approaches in hepatocellular
carcinoma. J Clin Gastroenterol 2013;41(9):839-54.
20. Rasyid A. Temuan Ultrasonografi Kanker Hati Hepato Selular (Hepatoma).
Diakses dari http:/ repository.usu.ac.id/bitstream.pdf April 2013
21. Saffroy R, Pham P, Reffas M, et al. New perspectives and strategy research
biomarkers for hepatocellular carcinoma. Clin Chem Lab Med 2012;45(9):116979.
22. Seeff
LB.
Introduction:
The
burden
carcinoma. Gastroenterology 2013; 127(5):S1-4.

of

hepatocellular

23. Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion
and histologic grade: Implications for selection of surgical treatment for
hepatocellular carcinoma. Liver Transpl. 2014;11(9):1086-92.
24. Kim WR. The use of decision analytic models to inform clinical decision making
in the management of hepatocellular carcinoma. Clin Liver Dis 2012;9(2):225-34.
25. Cormier JN, Thomas KT, Chari RS, et al. Management of hepatocellular
carcinoma. J Gastrointest Surg 2013;10(5):761-80.
26. Georgious CS. Survival benefit in hepatocellular carcinoma: when an innovative
transplant strategy might benefit oncology. The Lancet Oncology 2011;12(7):611
2.
27. Forner A, Hessheimer AJ, Isabel Real M, et al. Treatment of hepatocellular
carcinoma. Crit Rev Oncol Hematol 2013;60(2):89-98.

28. Llovet JM, Vilana R, Bru C, et al. Increased risk of tumor seeding after
percutaneous
radiofrequency
ablation
for
single
hepatocellular
carcinoma. Hepatology 2014; 33(5):1124-9.
29. Bosch FX, Ribes J, Diaz M, et al. Primary liver cancer: worldwide incidence and
trends. Gastroenterology. 2014;127(5):S5-S16.
30. Marrero JA, Fontana RJ, Barrat A, et al. Prognosis of hepatocellular carcinoma:

comparison of 7 staging systems in an American cohort. Hepatology 2012 Ap;

41(4):707-16.